Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Danta

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|January 22, 2020
The safety and pharmacokinetics of metformin in patients with chronic liver diseaseFelicity C Smith, Sophie L Stocker, Mark Danta, et al.
Journal of Clinical Immunology|January 20, 2018
Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable ImmunodeficiencyElissa K Deenick, Adrienne Morey, Mark Danta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?David A Brown, Kenneth W Hance, Connie J Rogers, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patientsJacob Nattermann, Martin Vogel, Thomas Berg, et al.
The Journal of Infectious Diseases|January 25, 2011
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis CJacob Nattermann, Martin Vogel, Hans Dieter Nischalke, et al.
Public Health Research & Practice|August 7, 2019
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancersMarianne F Weber, Henry M Marshall, Nicole Rankin, et al.
International Journal of Molecular Sciences|January 22, 2021
CD73<sup>+</sup> CD127<sup>high</sup> Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 InfectionNabila Seddiki, John Zaunders, Chan Phetsouphanh, et al.
Journal of Virus Eradication|June 14, 2019
Possible clearance of transfusion-acquired <i>nef</i>/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotypeJohn Zaunders, Wayne B Dyer, Melissa Churchill, et al.
Journal of Gastroenterology and Hepatology|August 28, 2022
Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort studyDavid Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, et al.
Immunity|January 16, 2025
A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune diseaseClara Young, Mandeep Singh, Katherine J L Jackson, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|January 22, 2020
The safety and pharmacokinetics of metformin in patients with chronic liver diseaseFelicity C Smith, Sophie L Stocker, Mark Danta, et al.
Journal of Clinical Immunology|January 20, 2018
Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable ImmunodeficiencyElissa K Deenick, Adrienne Morey, Mark Danta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?David A Brown, Kenneth W Hance, Connie J Rogers, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patientsJacob Nattermann, Martin Vogel, Thomas Berg, et al.
The Journal of Infectious Diseases|January 25, 2011
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis CJacob Nattermann, Martin Vogel, Hans Dieter Nischalke, et al.
Public Health Research & Practice|August 7, 2019
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancersMarianne F Weber, Henry M Marshall, Nicole Rankin, et al.
International Journal of Molecular Sciences|January 22, 2021
CD73<sup>+</sup> CD127<sup>high</sup> Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 InfectionNabila Seddiki, John Zaunders, Chan Phetsouphanh, et al.
Journal of Virus Eradication|June 14, 2019
Possible clearance of transfusion-acquired <i>nef</i>/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotypeJohn Zaunders, Wayne B Dyer, Melissa Churchill, et al.
Journal of Gastroenterology and Hepatology|August 28, 2022
Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort studyDavid Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, et al.
Immunity|January 16, 2025
A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune diseaseClara Young, Mandeep Singh, Katherine J L Jackson, et al.
Pageof 8